Wellesley Pharmaceuticals   Report issue

For profit Phase 2
Founded: Newtown PA United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2016
NCT02646826
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Wellesley Pharmaceuticals, LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

acetaminophen (tylenol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Nocturia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1